Patents by Inventor Mark Lovell

Mark Lovell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of MCI and Alzheimer's disease
    Patent number: 9968574
    Abstract: The present invention provides, among other things, therapeutic compositions and methods that can effectively treat, slow or prevent a neurological disease (e.g., a neurodegenerative disease, e.g., mild cognitive impairment (MCI) or Alzheimer's disease (AD)), in particular, based on therapeutically effective amount of nifedipine, oxidized or nitroso nifedipine derivatives, lactam (e.g., a compound of formula (Ic) or (Ic-i), e.g., NFD-L1), thyroxine (T4), triiodothyronine (T3) and combinations thereof.
    Type: Grant
    Filed: November 18, 2010
    Date of Patent: May 15, 2018
    Assignee: The University of Kentucky Research Foundation
    Inventors: Mark Lovell, Bert Lynn
  • TREATMENT OF MCI AND ALZHEIMER'S DISEASE
    Publication number: 20110118299
    Abstract: The present invention provides, among other things, therapeutic compositions and methods that can effectively treat, slow or prevent a neurological disease (e.g., a neurodegenerative disease, e.g., mild cognitive impairment (MCI) or Alzheimer's disease (AD)), in particular, based on therapeutically effective amount of nifedipine, oxidized or nitroso nifedipine derivatives, lactam (e.g., a compound of formula (Ic) or (Ic-i), e.g., NFD-L1), thyroxine (T4), triiodothyronine (T3) and combinations thereof.
    Type: Application
    Filed: November 18, 2010
    Publication date: May 19, 2011
    Applicant: The University of Kentucky Research Foundation
    Inventors: Mark Lovell, Bert Lynn
  • TREATMENT OF MCI AND ALZHEIMER'S DISEASE
    Publication number: 20100292281
    Abstract: The present invention provides, among other things, therapeutic compositions and methods that can effectively treat, slow or prevent mild cognitive impairment (MCI) or Alzheimer's disease (AD), in particular, based on therapeutically effective amount of nifedipine, oxidized or nitroso nifedipine derivatives, thyroxine (T4), triiodothyronine (T3) and combinations thereof.
    Type: Application
    Filed: May 13, 2010
    Publication date: November 18, 2010
    Applicant: The University of Kentucky Research Foundation
    Inventors: Mark Lovell, Bert Lynn
  • Gas bag module
    Patent number: 6783149
    Abstract: The invention relates to a gas bag module of several components, which comprise a least a carrier element, a gas generator and a gas bag. At least one elastic element is provided and at least one of the components is mounted in the gas bag module so as to be neutralized with regard to vibration by means of the at least one elastic element consisting of silicone.
    Type: Grant
    Filed: March 28, 2002
    Date of Patent: August 31, 2004
    Assignee: TRW Automotive Safety Systems GmbH & Co. KG
    Inventors: Mark Lovell, Thorsten Nottebaum
  • Gas bag module
    Publication number: 20020140210
    Abstract: The invention relates to a gas bag module of several components, which comprise a least a carrier element, a gas generator and a gas bag. At least one elastic element is provided and at least one of the components is mounted in the gas bag module so as to be neutralized with regard to vibration by means of the at least one elastic element consisting of silicone.
    Type: Application
    Filed: March 28, 2002
    Publication date: October 3, 2002
    Applicant: TRW Automotive Safety Systems GmbH & Co. KG
    Inventors: Mark Lovell, Thorsten Nottebaum